Affiliation:
1. Immunology and Histocompatibility Laboratory Saint‐Louis Hospital Paris France
2. MICS—Research laboratory in Mathematics and Computer Science at CentraleSupélec Gif‐Sur‐Yvette France
3. INSERM U976 Eq. 3 HIPI IRSL Saint‐Louis Hospital Université de Paris‐Cité Paris France
Abstract
Assessing donor/recipient HLA compatibility at the eplet level requires second field DNA typings but these are not always available. These can be estimated from lower‐resolution data either manually or with computational tools currently relying, at best, on data containing typing ambiguities. We gathered NGS typing data from 61,393 individuals in 17 French laboratories, for loci A, B, and C (100% of typings), DRB1 and DQB1 (95.5%), DQA1 (39.6%), DRB3/4/5, DPB1, and DPA1 (10.5%). We developed HaploSFHI, a modified iterative maximum likelihood algorithm, to impute second field HLA typings from low‐ or intermediate‐resolution ones. Compared with the reference tools HaploStats, HLA‐EMMA, and HLA‐Upgrade, HaploSFHI provided more accurate predictions across all loci on two French test sets and four European‐independent test sets. Only HaploSFHI could impute DQA1, and solely HaploSFHI and HaploStats provided DRB3/4/5 imputations. The improved performance of HaploSFHI was due to our local and nonambiguous data. We provided explanations for the most common imputation errors and pinpointed the variability of a low number of low‐resolution haplotypes. We thus provided guidance to select individuals for whom sequencing would optimize incompatibility assessment and cost‐effectiveness of HLA typing, considering not only well‐imputed second field typing(s) but also well‐imputed eplets.
Subject
Genetics,Immunology,Immunology and Allergy
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献